Evidence map›Paper›PMID 23782672›Full record

Trial reportTrials2013

Translating comparative effectiveness of depression medications into practice by comparing the depression medication choice decision aid to usual care: study protocol for a randomized controlled trial.

Annie LeBlanc, Amy E Bodde, Megan E Branda, Kathleen J Yost, Jeph Herrin, Mark D Williams, Nilay D Shah, Holly Van Houten, Kari L Ruud, Laurie J Pencille and 1 more

Registry-linked trialOpen access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01502891 (Translation of Comparative Effectiveness of Depression Medications Into Practice), which is not on this map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
12.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01502891 nacompletednot on this map

Translation of Comparative Effectiveness of Depression Medications Into Practice

TypeinterventionalSponsorVictor MontoriRan2011 to 2013Enrolled301ConditionsDepressionArmsDecision Aid
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2017
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Impact of Cost Conversation on Decision-Making Outcomes.Mayo Clinic proceedings. Innovations, quality & outcomes · 2021
    Article
  8. Using Shared Decision-Making Tools and Patient-Clinician Conversations About Costs.Mayo Clinic proceedings. Innovations, quality & outcomes · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Annie LeBlancDepartment of Health Sciences Research, Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN, USA. leblanc.annie@mayo.edu.
Amy E Bodde
Megan E Branda
Kathleen J Yost
Jeph Herrin
Mark D Williams
Nilay D Shah
Holly Van Houten
Kari L Ruud
Laurie J Pencille
Victor M Montori
Mayo Clinic · USMayo Clinic in Florida · USMayo Clinic in Arizona · USWinnMed · USYale University · US

Funding

Translation of comparative effectiveness of depression medications into practiceR18HS019214 · AHRQ · MAYO CLINIC ROCHESTER · PI MONTORI, VICTOR MANUEL · 2010 to 2010
$1.5M
AHRQ HHS IADAPT-1 R18 HS019214
6 · The paper itself

Abstract

backgroundComparative effectiveness research (CER) documents important differences in antidepressants in terms of efficacy, safety, cost, and burden to the patient. Decision aids can adapt this evidence to help patients participate in making informed choices. In turn, antidepressant therapy will more likely reflect patients' values and context, leading to improved adherence and mood outcomes. METHODS/

designThe objective of this study is to develop the Depression Medication Choice decision aid for use during primary care encounters, and to test its efficacy by conducting a clustered practical randomized trial comparing the decision aid to usual depression care in primary care practices.We will use a novel practice-based, patient-centered approach based on participatory action research that involves a multidisciplinary team of designers, investigators, clinicians, patient representatives, and other stakeholders for the development of the decision aid. We will then conduct a clustered practical randomized trial enrolling clinicians and their patients (n = 300) with moderate to severe depression from rural, suburban and inner city primary care practices (n = 10). The intervention will consist of the use of the depression medication choice decision aid during the clinical encounter. This trial will generate preliminary evidence of the relative impact of the decision aid on patient involvement in decision making, decision making quality, patient knowledge, and 6-month measures of medication adherence and mental health compared to usual depression care. DISCUSSION: Upon completion of the proposed research, we will have developed and evaluated the efficacy of the decision aid depression medication choice as a novel translational tool for CER in depression treatment, engaged patients with depression in their care, and refined the process by which we conduct practice-based trials with limited research footprint.

trial registrationClinical Trials.gov: NCT01502891.

Indexed as

Decision Support TechniquesPatient-Centered CarePatient SelectionPrimary Health CareResearch DesignAntidepressive AgentsClinical ProtocolsComparative Effectiveness ResearchDepressionHumansMedication AdherenceMental HealthMidwestern United StatesSurveys and QuestionnairesTime FactorsTreatment OutcomeAntidepressive Agents

Identifiers

PMID23782672
PMCPMC3663744
OpenAlexW2147593392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.